Why today is a big day for Pro Medicus shares

Records are being broken by this share on Monday. What's going on?

| More on:
Excited group of friends sitting on sofa watching sports on TV and celebrating.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares have continued their record-breaking run on Monday.

In morning trade, the health imaging technology company's shares have risen over 2% to a record high of $226.79.

This means that its shares are now up a staggering 160% since this time last year.

Why are Pro Medicus shares breaking records today?

Investors have been buying the company's shares this morning following the release of its annual general meeting presentation before the main event.

While that presentation focused a lot of what happened in FY 2024, there was also commentary on the future that appears to have got investors excited.

But let's start with a look at the last financial year. Commenting on the 12 months, Pro Medicus' chair, Peter Kempen, said:

FY2024 was another record year for the company with revenue increasing by 29.3% to $161.5 million and net profit after tax increasing by 36.5% to $82.8 million. The Company continued to be cash flow positive with retained cash and liquid investments increasing from $121.5 million to $155.4 million, after a A$2.77m buyback of shares in February/March, a $US5m investment in cardiac CT AI company Elucid and paying increased dividends.

Pleasingly, Kempen then stated that "the Board anticipates FY25 will be another strong year." He then adds:

The budget for the current financial year has been determined recognising anticipated continuing strong growth, from both existing and new clients. I am pleased to advise that results to date are ahead of budget on a constant currency basis and an Australian dollar basis, despite some volatility in currency markets during the period. We anticipate that the second half of the financial year will be stronger than the first half, as is traditionally the case.

Big future

Also giving Pro Medicus shares a boost is likely to be a part of its presentation which focuses on its total addressable market (TAM).

The company notes that it has a huge TAM in the United States. It highlights that there are 650 million exams performed each year and this is growing by 2% to 3% per annum.

It points out that Pro Medicus' best in class Visage platform is able to address 100% of this TAM from a product perspective and 85% from a commercial perspective.

Whereas at present, its current penetration is just a modest but lucrative 7%. It believes this provides it with a "large addressable runway." Management also sees opportunities to leverage artificial intelligence to drive further growth.

All in all, the future looks bright for Pro Medicus and its shares.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Man holding a calculator with Australian dollar notes, symbolising dividends.
Technology Shares

$10,000 invested in DroneShield shares 5 years ago is now worth…

You might be laughing all the way to the bank if you had done this.

Read more »

Happy woman working on a laptop.
Technology Shares

Up 60% since April, why this $40 billion ASX 200 tech stock remains a 'compelling buy' today

A leading expert believes this $40 billion ASX 200 tech stock has a lengthy growth runway ahead of it yet.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Technology Shares

DroneShield shares sink 7% despite big news

Let's see what's going on with this market darling on Thursday.

Read more »

A man activates an arrow shooting up into a cloud sign on his iPad.
Technology Shares

Up 25% since April, is it too late to buy Xero shares today?

A leading expert gives his verdict on the growth outlook for Xero shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Technology Shares

2 amazing ASX tech shares I wish I'd bought last year

These tech companies are among the world’s best companies.

Read more »

A man in a business suit and tie places three wooden blocks with the numbers 1, 2, and 3 on them on top of each other.
Broker Notes

3 reasons to buy this booming ASX All Ords tech stock today

A leading broker forecasts more gains to come from this surging ASX All Ords tech stock.

Read more »

Man ponders a receipt as he looks at his laptop.
Technology Shares

Brokers rerate 3 leading ASX 200 tech stocks

Experts reveal their ratings on the ASX 200 tech sector's three biggest companies.

Read more »

Hologram of a man next to a human robot, symbolising artificial intelligence.
AI Stocks

Why Macquarie forecasts a big rebound for these 2 quality ASX All Ords tech stocks

Macquarie expects a big rebound is coming for these AI linked, ASX All Ords tech stocks.

Read more »